Table 11

Tumor characteristics for primary breast carcinoma analyzed for GIRK1 expression

Case	GIRK1^a	CI^b	No. of total LN	No. of positive LN	Age (yr)	Size (cm)	Grade	ER
805	0	0–0.07	9	0	52	1	1	+
4046	0	0–0.03	23	0	52	1.1	3	−
926	0.2	0.2–0.2	18	0	69	1.8	3	+
2394	0.2	0.2–0.27	10	0	56	1	2	−
1647	0.3	0.2–0.3	8	0	37	1.8	3	+
6077	0.3	0.2–0.6	6	0	54	4.5	1	−
1828	0.3	0.3–0.37	13	0	66	2.2	2	+
2506	0.4	0–3.6	22	0	48	2.8	1	+
2495	0.4	0.3–0.46	12	0	46	1	1	+
3968	0.4	0.3–0.4	11	0	54	2	2	+
980	0.4	0.4–0.5	8	0	55	2	3	−
1914	0.4	0.4–0.6	19	0	64	0.9	1	+
2097	0.6	0.5–0.6	9	0	54	0.9	1	+
1897	0.8	0.3–2.0	12	0	55	0.8	2	+
1241	0.9	0.4–2.2	13	0	81	1	3	+
1740	1.1	0.9–1.5	22	0	41	2.2	2	+
6757	2.8	1.9–4.1	15	0	54	2.2	3	+
6263	4.1	4–4.4	8	0	30	0.9	2	+
4149	4.6	3.8–5.5	6	0	53	1.7	3	+
4162	6.2	5.8–9.1	19	0	30	1.6	3	−
2468	8.6	7.3–10.1	12	0	70	4.8	2	+
5990	8.6	8.6–10	19	0	59	1.4	2	+
81	8.8	6.1–12.8	13	0	33	1.9	1	+
5949	13.7	13.6–14.2	14	0	72	0.9	2	+
6185	13.8	10.9–17.5	19	0	53	1.2	2	+
6435	14.8	14.1–15.6	11	0	46	1.8	2	+
939^c	27.4	25.6–31	11	0	66	1.7	2	+
2591	37.9	32.3–44.5	12	0	68	1	2	−
1466	39.3	32.1–48	10	0	67	2	3	+
4041	142.5	130.6–156	14	0	66	1.6	1	+
2175	0.6	0.5–0.7	9	1	71	1.5	1	+
1290	0.7	0.5–1	8	1	73	1.8	2	+
2588	0.7	0.6–0.9	13	1	43	2	1	+
7333	7.1	6.8–7.4	18	1	39	1.3	2	+
6257	9.8	8.6–11.2	8	1	34	1.3	3	−
3125	145.5	125.6–201.3	15	1	65	3	2	+
5620	186.1	165–210	8	1	59	1.5	1	+
4674	1.4	1.3–1.5	10	2	51	2	3	+
5008	148.1	147.3–181	11	2	48	5.5	3	−
339	335.5	302.7–378.6	14	2	51	3	3	−
1375	0.93	0.7–1.17	10	2	29	3.6	1	+
2151	0.1	0–0.1	7	3	49	1.5	3	+
585	27.7	23.9–32	8	3	88	4.5	2	+
7237	53.6	27.1–119	11	3	59	2	2	+
1191	67.6	66.3–70.1	19	3	59	0.9	2	+
5893T	282.1	212.1–375	20	3	43	5	2	+
6370T	0.9	0.7–1.2	41	4	46	2.5	3	−
4057	704.3	658–754	5	4	62	1.4	2	+
3873	1.6	1.3–2.1	21	6	72	3.5	3	−
6619	453.5	350.1–588	11	6	69	5	3	−
5	0.1	0.1–0.2	11	8	73	2	2	+
4106	74.3	68–81.3	12	8	60	2	3	+
5866	89.3	82.4–97	15	8	53	1.1	3	+
2153	0	0–0	28	13	51	2	2	−
3130	27.3	25.8–29	20	19	46	4.4	3	−
6873	9.1	7.1–11.7	27	26	84	12	3	+

a Fold increase above control.
b CI (95% confidence intervals); LN, lymph node; ER, estrogen receptor status (as measured by immunohistochemistry); Grade, Bloom Richardson grade.
c Cases shown in bold overexpress GIRK1.